Phathom Pharmaceuticals, Inc. (PHAT) earnings date
Mar 4, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 27% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 14 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Oct 29, 2026 | before open | 29 | 8-K |
| Q2 FY2026 | Thu, Jul 30, 2026 | before open | 30 | 8-K |
| Q1 FY2026 | Thu, Apr 30, 2026 | before open | 30 | 8-K |
| Q4 FY2025 | Thu, Feb 26, 2026 | before open | 57 | 8-K |
| Q3 FY2025 | Thu, Oct 30, 2025 | before open | 30 | 8-K |
| Q2 FY2025 | Thu, Aug 7, 2025 | before open | 38 | 8-K |
| Q1 FY2025 | Thu, May 1, 2025 | before open | 31 | 8-K |
| Q4 FY2024 | Thu, Mar 6, 2025 | before open | 65 | 8-K |
What they guided beta
| Q3 FY2026 | "Reaffirmed full-year 2026 financial guidance" exhibit |
| Q3 FY2026 | "We remain confident in our ability to meet our financial obligations and deliver on our full-year 2026 guidance.”" exhibit |
| Q3 FY2026 | "The first subject has been dosed, and sites are currently enrolling across the U.S. Topline results are expected in the first quarter 2028." exhibit |
| Q3 FY2026 | "Phathom expects to report topline results during the fourth quarter 2026 for the 12-week blinded treatment portion of its Phase 2 pHalcon-EoE-201 trial evaluating VOQUEZNA in patients with Eosinophilic Esophagitis (EoE)." exhibit |
| Q3 FY2026 | "On October 23, 2026, FDA opened a public comment docket on issues raised in the litigation, with comments due November 23, 2026." exhibit |
| Q2 FY2026 | "Updated full-year 2026 financial guidance" exhibit |
| Q2 FY2026 | "“Our more moderate revenue guidance still reflects meaningful growth in the second half of 2026.”" exhibit |
| Q2 FY2026 | "First subject enrollment for the planned Phase 3 trial is expected during the fourth quarter of 2026." exhibit |
| Q2 FY2026 | "Topline results from the 12-week blinded treatment portion of the trial are expected during the fourth quarter of 2026." exhibit |
| Q2 FY2026 | "The decrease of $31.2 million compared to the second quarter 2025 was attributable to cost savings associated with lower commercial promotional spend, lower personnel-related expenses, and lower third-party spend." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/PHAT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/PHAT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/PHAT/"><img src="https://veritasdata.dev/embed/PHAT.svg" alt="PHAT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/PHAT/)
Script
<script async src="https://veritasdata.dev/embed/PHAT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/PHAT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.